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New generations of analytical techniques for imaging of metals are pushing hitherto boundaries
of spatial resolution and quantitative analysis in biology. Because of this, the application of these
imaging techniques described herein to the study of the organization and dynamics of metal
cations and metal-containing biomolecules in biological cell and tissue is becoming an important
issue in biomedical research. In the current review, three common metal imaging techniques in
biomedical research are introduced, including synchrotron X-ray fluorescence (SXRF) microscopy,
secondary ion mass spectrometry (SIMS), and laser ablation inductively coupled plasma mass
spectrometry (LA-ICP-MS). These are exemplified by a demonstration of the dopamine-Fe
complexes, by assessment of boron distribution in a boron neutron capture therapy cell model,
by mapping Cu and Zn in human brain cancer and a rat brain tumor model, and by the analysis
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of metal topography within neuromelanin. These studies have provided solid evidence that
demonstrates that the sensitivity, spatial resolution, specificity, and quantification ability of metal
imaging techniques is suitable and highly desirable for biomedical research. Moreover, these novel
studies on the nanometre scale (e.g., of individual single cells or cell organelles) will lead to a
better understanding of metal processes in cells and tissues.
1. Introduction
Metals are vital components of chemistry and life.1 An
estimated one-third of all proteins require metal ions as
cofactors for protein function.2 Indeed, the homeostasis of
metal ions [e.g., iron (Fe), copper (Cu), zinc (Zn), manganese
(Mn), potassium (K), sodium (Na), and calcium (Ca)] is
essential for many biological activities.3 The surplus or deficit
of these elements may lead to various human diseases. For
example, human Menkes disease is a genetic disorder of Cu
metabolism caused by mutations of ATP7A. A lack of this
protein results in progressive neurodegeneration and vascular
tissue abnormalities; death by 3 years of age is typical.4 In
many neurodegenerative diseases, metal-containing deposits
(such as those found in Wilson’s, Parkinson’s, and Alzheimer’s
disease) or metal deficiencies (such as the lack of copper in
Menkes disease; mutations of Menkes disease gene coding for
ATP7A that is responsible for excretion of copper from cells
and delivery of this cofactor to copper containing enzymes
such as SOD3 in the trans-Golgi apparatus5) were observed
within the brain. Therefore, the functions of metal ions in
cellular regulation and signaling as they apply to the healthy or
disease states, are of principal interest in biomedicine.
From a chemical standpoint, the inventory of metals and
their species in cells and tissues (including metalloproteins
and/or metalloenzymes) is termed as the metallome and the
analysis thereof metallomics.6 From a biomedical standpoint,
metallomics investigates how the metals are bound to biomo-
lecules, characterizes metalloproteins and/or metalloenzymes
and studies the mechanisms of enzymatic and biochemical
reactions, and provides a novel prospective to investigate the
pathophysiological mechanism of diseases. Metallomics will
also help to better understand the basic cellular nutritional
requirements for essential metals. It is anticipated that the
use of metallomics will also contribute to new drug design,
diagnostics, and therapeutics involving metal complexes.
Moreover, extending the concept of metallomics into bio-
medical research has resulted in new research subjects. As a
useful example, vascular metallomics, a branch of vascular
biology, is emerging.7 This methodology is used to study the
biological role of metal ions and their signaling pathways in the
vasculature, using techniques including molecular biology, cell
biology, genetics, and analytical chemistry.
In general, all essential, beneficial, and toxic metals are not
homogeneously distributed in biological cells and tissues.
Thus, more fruitful insights into physiology and
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pathophysiology may result, when metallomics studies are
guided by the spatial information provided by bioimaging
techniques. Of interest are the organization and dynamics of
metals and metal-containing biomolecules at the cellular and
tissue levels, especially in the study of human samples at
different stages of disease, and in animal models with and
without experimental therapies targeting the metabolism of
selected metals or the introduction of the metals themselves.
This review is not intended to be a comprehensive literature
review of various imaging techniques. Instead, it is written
primarily as a commentary guide and even a tutorial to the
application of three advanced metallomics techniques SXRF,
Table 1 Overview of metals and other elements mentioned in this manuscript
Element Symbol Atomic mass Stable isotopesa Function mentioned in this manuscript
Argon Ar 39.95 36Ar, 38Ar, 40Ar Primary ion beam of SIMS; a carrier gas in ICP-MS
Bismuth Bi 208.98 209Bi Primary ion beam of SIMS
Boron B 10.81 10B, 11B Boron neutron capture therapy; boron distribution in cell
Bromine Br 79.90 79Br, 81Br Bromine distribution in tissue
Calcium Ca 40.08 40Ca, 42Ca, 43Ca, 44Ca, 46Ca,
48Ca
Calcium distribution in cell and tissue
CarbonC12.0112C, 13CPrimary ion beam of SIMS
Caesium Cs 132.91 133Cs Primary ion beam of SIMS
Copper Cu 63.55 63Cu, 65Cu Copper distribution in cell and tissue
Gallium Ga 69.72 69Ga, 71Ga Primary ion beam of SIMS
Gold Au 196.97 197Au Primary ion beam of SIMS; Au plates used for embedding biological sample
Iron Fe 55.85 54Fe, 56Fe, 57Fe, 58Fe Iron distribution in cell and tissue
Lithium Li 6.94 6Li, 7Li Generated from boron nuclear reaction in biological tissue
Manganese Mn 54.94 55Mn Manganese distribution in cell and tissue
Oxygen O 16.00 16O, 17O, 18O Primary ion beam of SIMS
Phosphorus P 30.97 31P Phosphorus distribution in cell and tissue
Potassium K 39.10 39K, 41K Potassium distribution in cell and tissue
Selenium Se 78.96 74Se, 76Se, 77Se, 78Se, 80Se, 82Se Selenium distribution in cell and tissue
Silicon Si 28.09 28Si, 29Si, 30Si Silicon plates used for embedding biological sample
Silver Ag 107.87 107Ag, 109Ag Silver needle used to defocused laser beam in nano-LA-ICP-MS
Sodium Na 22.99 23Na Sodium distribution in cell and tissue
Sulfur S 32.07 32S, 33S, 34S, 36S Sulfur distribution in cell and tissue
Zinc Zn 65.39 64Zn, 66Zn, 67Zn, 68Zn, 70Zn Zinc distribution in cell and tissue
a Based on the Berkeley Laboratory Isotopes Project.
Table 2 Comparison of the three common metal imaging techniques
SIMS
SXRF LA-ICP-MSStandard NanoSIMS
Sample material Semi-thin or thin sections of
epoxide-embedded material,
vacuum compatible
Hydrated, dried, or embedded material.
Vacuum not obligatory
Native 10–40 mm cryo-sections, laser ablated
at atmospheric pressure
Field of view few mm2 0.1 mm2 Sub mm2 to cm2 0.01–200 cm2
Spatial resolution 0.1–10 mm 450 nm 4150 nm 5–200 mm
Penetration depth 1–10 nm 100–1000 mm ablation of the section thickness
Mass range/u Standard: 12–250 6–250
10–500 10–250
MeSIMS: 1500
Detection limit/
g g1
at 10 mm spot
diam.
50 nm spot diam. 2  15 mm2 spota 100 mm laser beam
Na 1010 102f — 107
P 108 104a; 105b 107
Fe 107a; 105b; o107c 107
Cu 108e 102f 107a 108
Zn 107 102f 107a 107
Dynamic range 105 102f 103d 4109
Number of elements 5–7
(multicollector
SIMS)
PracticallyE20 40 (quadrupole ICP-MS)
Additional detection
capability
Isotopes; biomolecules
(o2000 Da); quantitative
imaging, but difficult due to
matrix effect
Oxidative states; non-destructive;
quantitative imaging
Isotopes; quantitative imaging
Note that parameters significantly vary for each individual application. Values from typical settings are given for rough orientation only. Data adapted
from Becker, Inorganic mass spectrometry 2007 and EAG AN339,a Somogyi et al., 2001 at the ESRF ID18F beamline, a highly stable end station
dedicated to quantitation.43 b Cotte et al., 2007 at the ESRF ID21 beamline, 0.4  1 mm2 spot.44 c Ortega et al., 2007 at the ESRF ID22 beamline at
100 nm spot diameter (0.05 ng cm2; the area mass of cell being 100 mg cm2).13a d The dynamical range of XRF largely depends on the element
composition in the sample due to spectral overlap specially of elements with neighboring z number. e Sykes et al., 1994.45 f CAMECAproduct brochure.
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SIMS, and LA-ICP-MS. Table 1 provides a quick overview of
metals and other elements mentioned in this manuscript.
Table 2 compares the basic operational parameters of these
techniques. Among these parameters, the sample material and
the penetration depth will help us to choose the most suitable
technique for sampling. Field of view, spatial resolution,
mass range, detection limit, dynamic range, the number
of simultaneous masses or elements, and the capability
to identify isotopes and oxidative states will help us to
understand the advantages and limitations of each technique.
Moreover, the reader requiring further information regarding
instrumentation and measurement procedures (such as the
development and production of biological samples, data
acquisition and calibration protocols) is directed to several
excellent reviews, such as those of Fahrni8 (SXRF), Boxer
et al.9 (SIMS), and Becker et al.10 (LA-ICP-MS). Moreover, a
very recent exhaustive review in metal bioimaging from Fahrni
group is highly recommended.11
Techniques commonly used in bioimaging of metals
SXRF microscopy uses an X-ray beam to excite the inner
shell electrons and, ultimately, to generate measurable X-ray
fluorescence. Each element has a unique fluorescence spectrum,
so this technique allows for multi-element analysis. Another
advantage of using SXRF is that the sample is not damaged
during the measurements. SXRF provides qualitative and
quantitative information on the topography, concentration
and oxidative state of metal cations12 (see Table 2 for
the basic characteristics of SXRF). SXRF instruments
with micrometre or higher resolution are available at several
synchrotron sources, such as the Advanced Photon Source
(Argonne National Laboratory, Argonne, USA; www.aps.anl.
gov), the European Synchrotron Radiation Facility (Grenoble,
France; www.esrf.eu), and the SPring-8 Facility (Hyogo, Japan;
www.spring8.or.jp/en/). For instance, an SXRF nanoprobe
(nano-SXRF) was developed at the European Synchrotron
Radiation Facility, which has a 90 nm X-ray beam.13
In addition to SXRF, X-ray based imaging techniques also
include bench-top X-ray fluorescence analysis (XRF), proton
or particle induced X-ray emission (PIXE), electron probe
X-ray microanalysis (EPXMA) or scanning- or transmission
electron microscopy energy dispersive X-ray analysis (SEM-
EDS or TEM-EDS). Among these techniques, SXRF has the
highest element sensitivity due to absence of a bremsstrahlung
background, while EPXMA provides the highest spatial
resolution on very thin samples. Bench-top micro-XRF is
commercially available, integrating mapping capacities at
30 mm spatial resolution and detection limits at approximately
10–100 ppm (Model SEA5120A, SII NanoTechnology Inc.,
Tokyo, Japan, www.siint.com). There are two other bench-top
micro-XRF systems, one is commercialized by Horiba Jobin-
Yvon (Japan) and the other one by EDAX (USA). SEM-EDS
or TEM-EDS platforms are also commercially available (e.g.,
Bruker QUANTAXt and Zeiss AURIGAt).
SIMS is a sensitive surface analytical mass spectrometric
technique for imaging of elements, isotopes or molecules, and
depth profiling and trace analysis. This can be used, for
example, for the determination of contamination and element
distribution on solid sample surfaces, such as biological surfaces
or tissue sections. In SIMS, the components of the solid sample
surface are sputtered during bombardment with a focused
primary ion beam [e.g., argon (Ar), caesium (Cs), gallium
(Ga), oxygen (O), gold (Au), or bismuth (Bi) cluster ions
(Table 1)] of sufficiently high ion energy (from 0.2–40 keV) in
a high-vacuum ion source.14 The positively or negatively
charged secondary ions generated during the sputtering
process are extracted into a double focusing sector field,
quadrupole-based or time-of-flight (ToF) mass spectrometer
with single ion detection. ToF-SIMS (e.g., ION-TOF,
Mu¨nster, Germany) is equipped with three primary ion
sources for sputtering of sample surface, and has a higher
transmission of ions and a broader mass-to-charge range than
sector field SIMS. Table 2 introduces the basic characteristics
of SIMS.
Nano-SIMS, using a double focusing sector field mass
spectrometer, allows cellular imaging techniques to reach
high spatial resolution at the nanometre scale (e.g., 50 nm
using Cs primary ions or 150 nm using O primary ions). This
technique was first reported by Slodzian et al. in 1992.15 SIMS
instruments, Nano-SIMS 50 and 50 L from CAMECA
Instruments (Cameca, Courbevoie, France) are currently on
the market and are valuable imaging instruments in the
biosciences with nanometre resolution.16 Nano-SIMS is
equipped with multiple ion collectors for isotope analysis
and can analyze different isotopes simultaneously (see
Table 2). In general, SIMS can be performed on semi-thin
(300–500 nm) or thin (60–80 nm) sections of fixed, dehydrated
and embedded materials (electron microscope preparations)
set on clean silicon (Si), stainless steel, or Au plates. SIMS can
also be applied to native tissue mounted onto conventional
glass slides using charge compensation. SIMS using Bi, Au, or
carbon (C) cluster ion bombardment having spatial resolutions
of a few micrometres and below have been applied to an
increasing extent for biomedical applications, especially for
analyzing relatively small biomolecules (o1000 Da) in cells
and tissues.17
LA-ICP-MS uses a finely focused laser beam with
micrometre spot size to ablate a biological sample. The
ablated material is transported into the inductively coupled
plasma (ICP) source of the mass spectrometer using a carrier
gas (Ar). In the ICP, the ablated material is vaporized,
atomized and ionized. The formed ions are extracted into the
mass spectrometer and separated according to their mass-to-
charge ratio. Table 2 describes the basic characteristics of
LA-ICP-MS. Commercial laser ablation systems for sample
introduction include UP 213 or UP 266 (New Wave Research,
Fremont, CA),18 and LSX 213, 200 or 500 (CETAC
Technologies, Omaha NE, USA19) instruments, whereas
quadrupole-based and sector field ICP mass spectrometers
are commercially available from Thermo Fisher Scientific
(Bremen, Germany), Agilent Technologies (Santa Clara, CA,
USA), and Perkin Elmer Sciex (Toronto, Canada). LA-ICP-
MS has been established as a sensitive mass spectrometric
technique for the bioimaging of metals, metalloids, and
nonmetals at trace levels in microtome sections of biological
tissues. The optimum thickness of the specimen, in this case, is
20–30 mm.20 In LA-ICP-MS (under dry plasma conditions)
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interference problems are decreased compared to the use of
solution nebulization ICP-MS (under wet plasma conditions).
To quantify LA-ICP-MS data, reliable quantification
strategies such as the use of homogeneous matrix-matched
laboratory standards or solution-based calibration in
bioimaging of metals in tissues have been established.19,21
LA-ICP-MS has a multi-element capability (see Table 2) and
can provide quantitative specific metal distribution in thin tissue
sections of human or rodent brain.21,22 In addition, LA-ICP-MS
instrumentation is significantly more economical and easy to
handle than the other two techniques. Advanced quantitative
bioimaging techniques are employed in the BrainMet
(Bioimaging of Metals in Brain and Metallomics; www.
brainmet.de) laboratory for quantitative routine measurements
on diseased and healthy brain sections with spatial resolutions of
5 to 150 mm.23
Nano-LA-ICP-MS has recently been initiated to improve
the lateral resolution of LA-ICP-MS to the nanometre
resolution.24 The basic principle behind this innovation is to
insert a thin silver (Ag) needle into a defocused laser beam
using the near-field effect in laser ablation. The tip of the thin
needle acts as a magnifier. Thus, the focusing of photons is
300 times better than the best focusing lens and presents a
strong field enhancement. Becker et al.25 have established the
electrochemical etching of appropriate, very sharp Ag tips and
provided the first demonstration of the instrumentation in
elemental and isotopic analysis, while ablating and analyzing
nanometre scale spots in biological samples. Very recently, a
novel breakthrough of scaling down the bioimaging of metals
by the coupling of a laser microdissection apparatus to an
inductively coupled plasma mass spectrometry (LMD-ICP-
MS) instrument has been obtained.26 LMD-ICP-MS holds
great potential for medical and biological investigations on
small-size samples, such as single cells.
Bioimaging of metals at the single-cell level
Improvements in the design of SIMS and SXRF fulfil the
requirements for mapping biological trace metals at sizes that
are compatible with the analysis of most subcellular organelles,
including mitochondrion, lysosome, and secretory vesicle. For
example, SXRF can detect as little as 1018 g of Fe within a
cellular structure that has a diameter of only 90 nm.13a
Importantly, these techniques can detect the distribution of
metal ions within the specific sample directly, without changing
the natural charged states of the components of interest.
Until now, most imaging studies have focused on the
distribution studies of Fe in single cells, and, in particular, on
the association between Fe content and the pathogenesis of
neurodegenerative diseases. For example, Fe accumulates in the
brain of patients with Parkinson’s disease. This has been
proposed as a mechanism that contributes to the selective loss
of dopaminergic neurons during progression of the disease. In
addition, dopamine can form stable complexes with Fe
in vitro.27 Thus, it is reasonable to propose that Fe accumulates
in dopamine neurovesicles. Using SXRF microscopy at 90 nm
spatial resolution, Ortega and coworkers have provided convincing
data corroborating this hypothesis.13a To prepare samples for
Fig. 1 Nano-SXRF reveals the location of Fe within dopamine neurovesicles. Visible light microscopy of freeze-dried cells (A) and fluorescence
microscopy of the same freeze-dried cells (B) allow the distribution of dopamine to be determined. Panels C and D compare the same region imaged
using fluorescence to visualize dopamine and using nano-SXRF to localize the Fe. This study indicates that dopamine and Fe colocate within
200 nm structures that are characteristic of dopamine neurovesicles, as identified using fluorescence microscopy. The integration time per scan point
was varied from 300 ms to 1 s. The min-max range bar units are arbitrary. Reproduced from Ortega et al., PLoS One, 2007.13a
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SXRF study, cells were rinsed with phosphate buffer solution,
cryofixed at160 1C by plunge freezing into isopentane chilled
with liquid nitrogen, and freeze dried at35 1C. Fig. 1C and D
show that the distribution of dopamine detected by the
fluorescence microscopy is co-localized with Fe particles
detected by nano-SXRF. Furthermore, the authors find that
the inhibition of dopamine synthesis results in a decreased
vesicular storage of Fe. This appears the first direct evidence to
support the concept that dopamine-Fe complexes may exist in
dopaminergic neurons. This study also reported some
interesting discoveries relating to the subcellular topography
of Fe and Zn. First, whether treated with excess Fe or not, the
cells show the same subcellular topography of Fe. Second,
Fe-rich structures are found in the cytosol, in neurite
outgrowths, and at the distal ends of dopamine-producing
PC12 cells. However, K and Zn are not selectively distributed
to dopamine neurovesicles, contrary to observation made in
relation to the topography of Fe. Third, Zn has slightly elevated
levels in the nucleus. Note that Zn functions as a cofactor in the
Zn-finger transcription factors in the nucleus.28
In addition to SXRF, the metal subcellular distribution also
has been studied using SIMS. Boron (B) is a trivalent metalloid,
an essential plant nutrient and a component of boromycin—an
antibiotic compound produced by Streptomyces. This
element has been used for drug design29 and boron neutron
capture therapy (BNCT) for cancers, such as glioblastoma
multiforme.30 Glioblastoma multiforme is the most common
and aggressive type of primary brain tumors in humans. Boron
has two stable non-radioactive isotopes in nature, 10B and 11B.
When 10B is irradiated with low-energy thermal neutrons, a
nuclear reaction occurs that yields high linear energy transfer a
particles and recoils 7Li(lithium) nuclei. The impact of this
reaction is limited to 8 mm in tissue, equal to or less than one
cell diameter. BNCT has been designed utilizing the principle of
this neutron capture reaction. To better understand the
biological consequence of BNCT, it is necessary to study the
subcellular distribution of boron in biological samples. Using
SIMS isotope images with a 500 nm spatial resolution, Fig. 2
illustrates one study by Chandra and colleagues to image 12C,
39K, 23Na, 40Ca, and 10B distribution in human glioblastoma
T98G cells treated with a BNCT agent, p-boronophenylalanine
(BPA).31 One particular sample preparation (i.e., cryogenic
sandwich-fracture method) is also elegantly described in this
article. This method has great potential to apply for the sample
preparation with other metallomics techniques. Fig. 2a shows
an optical image of several fractured, freeze-dried cells. The
boundaries of the nuclei are labeled by a dotted line in two cells,
and the mitochondria-rich perinuclear cytoplasmic region is
indicated using arrows. Fig. 2e shows lower concentrations of
40Ca in the nucleus versus the cytoplasm. Fig. 2f shows a
distinctly lower concentration of 10B in the mitochondrion-
rich perinuclear cytoplasmic regions (cf. arrows), whereas
there is no discernible difference in the localization of 10B
between the nucleus and the remaining cytoplasm in T98G
interphase cells. By the way of contrast, in another
experiment, the BPA-treated T98G metaphase cells reveal
significantly lower concentration of 10B in their chromosomes
than in their cytoplasm. The cell cycle can be divided into two
periods: interphase and mitosis. Mitosis can be further divided
into following sequential phases: prophase, metaphase, ana-
phase, telophase and cytokinesis. The exciting finding suggests
the heterogeneity of B distribution in different cell cycle phases
(interphase versus metaphase). Overall, these studies demon-
strate that the metal bioimaging detected by SXRF and SIMS
provides a novel perspective to investigate the cellular events at
physiological and pathophysiological levels.
Bioimaging of metals at the organ and tissue levels
Conventional analytical techniques, such as ICP-MS and
atomic absorption spectrometry,32 examine the total metal ion
content after homogenization and digestion of the biological
tissues or organs. However, these techniques do not provide
sufficient information on the spatial distribution of metal ions.
Therefore imaging studies are important because many metal
ions (i.e., Cu, Fe, Zn, Mn, and Ca) are dispersed inhomogen-
eously in human tissues. Moreover, the biochemical reactions
and physiological functions of metal cations are determined not
only by their concentration, but also by their distribution within
the tissues. Heretofore, histological or histochemical staining
has been used to visualize the inhomogeneous distributions of
selected metal cations (e.g., Fe) within tissues.33 However,
Fig. 2 Subcellular metal distribution in interphase T98G human
glioblastoma cells using SIMS. Interphase T98G human
glioblastoma cells were treated with 110 mg mL1 BPA for 1 h. In
the reflected light Nomarski image (a), the boundaries of the nucleus of
two fractured freeze-dried cells are shown with dotted lines. The
mitochondria-rich perinuclear cytoplasmic regions are shown by
arrows in two cells. A SIMS analysis of the same cells revealing the
subcellular isotopic distributions of 12C (b), 39K (c), 23Na (d), 40Ca (e)
and 10B (f) is shown. The areas within the dotted lines show the
position of the nuclei, and arrows indicate the organelle-rich
perinuclear cytoplasmic region in SIMS images. The image
integration time of the CCD camera for the 39K and 23Na images
was 0.4 s. The 12C, 40Ca and 10B images were integrated for 2 min each.
Reproduced with permission from Wiley, 2008.31
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histological methods are relatively nonspecific, have a relatively
higher background and allow only one element to be mapped
per section. The quantification of images is also challenging. The
introduction of novel imaging techniques with multi-element
capability provides a valuable tool for overcoming these
limitations.
A vivid example of the application of this technique at the
tissue/organ level comes from studies into the role of Cu in
neovascularization and cancer. Recent clinical studies have
suggested that lowering Cu levels may be an effective antiangio-
genic approach to cancer treatment and that this is, at least in
part, due to the regulation of neovascularization (see the review
by Brewer34). Indeed, neovascularization is known to be sensi-
tive to the level of Cu.35 However, relatively little is known
about how Cu is distributed in cancerous tissues. Using
LA-ICP-MS, Becker’s group quantified the bioimages of metals,
including Cu and Zn, in histological sections of specimens from
patients with glioblastoma multiforme.36 The black area shown
in Fig. 3a indicates the area of the tumor. Surprisingly, there was
very little Cu detected in the tumor (see Fig. 3c). In contrast, the
black area shown in Fig. 3b indicates the area of the tumor
invasion zone, showing that Cu accumulated in the area around
Fig. 3 LA-ICP-MS reveals the location of Cu and Zn on a slice of a human glioblastoma sample. Adjacent sections underwent receptor
autoradiography using radioligands for peripheral benzodiazepine receptors (pBR), to define the area of the tumor (the black areas indicated by
white arrows in panel a), and for A1 adenosine receptors (A(1)AR) to define the tumor invasion zone (the black areas indicated by red arrows in
panel b). Areas of intratumoral hemorrhage are indicated by a dotted line (a and b). The sections containing the glioblastoma were entirely ablated
line by line with LA-ICP-MS. Laser scan speed was 40 mm s1. Laser beam diameter was 50 mm. The areas of intratumoral hemorrhage showed the
highest levels of Cu and Zn. The tumor invasion zone (high A1AR) and the cellular tumor mass region (high pBR) can be detected clearly using the
LA-ICP-MS measurements. Both elements are completely lacking within the tumor (c and d). Reproduced with permission from Elsevier, 2006.36
Fig. 4 LA-ICP-MS reveals the location of Cu and Zn in a cross section of a rat brain sample containing tumor tissue. The areas of tumor are
indicated by black dotted lines (a). The images of Cu (b) and Zn (c) are measured by LA-ICP-MS. Scan speed of laser ablation was 40 mm s1, laser
beam diameter 50 mm. Reproduced with the permission from Elsevier, 2008.22a
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the tumor (see Fig. 3c). This finding suggests that cell types other
than tumor cells may be sensitive to Cu, e.g., tumor-associated
macrophages, which usually surround the tumor. Another
possibility is that Cu may play different roles at different
stages of the progression of the disease and in different types
of tumor. The latter possibility was supported by another study
performed by the same group. In that study, F-98 glioma cells
(103) were implanted into the right caudate putamen of rat brain
using stereotaxic guidance. To prepare the sample for LA-ICP-
MS study, the brain was frozen in isopentyl alcohol at 50 1C
and cut into 20 mm thick slices at 16 1C for further LA-ICP-
MS.22a The authors find that the tumor tissue (the right brain
hemisphere) is more enriched in Cu and Zn than the control
tissue (the left brain hemisphere) (see Fig. 4b). However, in one
case, shortly after incubation with the tumor cells, the site of the
tumor became visible through a small depletion of Cu. Although
no mechanism has been discovered that can explain the
apparently contradictory results between these human versus
animal studies, nevertheless, these data indicate that the role of
Cu in cancer and neovascularization is more complicated than
the original assumption. Using metal imaging LA-ICP-MS,
more animal model studies can be developed, and further
clinical studies can be carried out to decipher this important
medical puzzle.
An important morphological change in aging neurons is an
accumulation of autophagic vacuoles occupied by
neuromelanin, a dark pigment synthesized within specific
catecholamine-producing neurons.37 Fedorow et al. described
three phases during the development of neuromelanin.38
Briefly, in phase I (2–3 years of age), the dopaminergic
neurons develop a faint and diffuse pigmentation; in phase II
(childhood and adolescence; 3–20 years of age), the cellular
volume filled with neuromelanin increases and becomes
darker; and in phase III (middle and later life), sustained
maturation of neuromelanin (pigment darkening) occurs
without further cellular volumetric increase. To further the
understanding of the cellular metallomics of neuromelanin,
Bohic and colleagues studied intracellular metallic topography
during human neuromelanin development using nano-
SXRF.39 Pigmented neurons can be clearly identified in the
unstained paraffin sections (Fig. 5a). Fig. 5b illustrates
an average metal spectrum from a region of interest
(B15  15 mm)2 within mature (phase III) neuromelanin
containing cells (in a 94 year old male). The elements
specifically distributed within the neuromelanin include S,
Ca, Fe, Cu, Zn, and Se (Fig. 5c). P is homogeneously
topographic throughout the cytoplasm and nucleus, whereas
Mn presents a faint and heterogeneous topography within the
neuromelanin (Fig. 5c). In additional studies, microdomains of
various elements are observed within the neuromelanin. These
irregular microdomains of micrometre or submicrometer size
are most apparent at phase III of pigment development
(aging). The authors further hypothesize that metal-rich
binding domains in neuromelanin represent physiologically
active structures that have developed as a functional
adaptation to efficiently bind potentially toxic metals without
the cell being overloaded with pigment. Moreover, the
dynamic changes in the levels of Ca, Fe, and Cu revealed in
this study enrich our knowledge about the use of metallomics
in aging. Ca concentration within brain tissue (substantia
nigra) is highest during prenatal development, prior to the
development of neuromelanin. Following development of
the pigment, the level of Ca gradually increased in the
neuromelanin from early childhood (3 years old, phase I) to
adolescence (15 years old, phase II), but declined during later
life. Neuromelanin-associated Fe steadily and significantly
increases with age; its level in the oldest subject (94 years
old) is almost 12 times higher than that observed at 3 years of
age. Cu content of neuromelanin also increases in early
adulthood but decreases in the aged brain. The biological
implication of the presence of metals in neuromelanin is also
notably discussed by the authors. For example, Mn is detected
only in the elderly and is inhomogeneously topographic
throughout the neuromelanin. This might result from an
elevated expression of manganese-SOD in response to
enhanced oxidative stress. Another possibility is that it
results from less effective mitochondria autophagocytosis in
senescent neurons, resulting in the transfer of mitochondrial
Mn to neuromelanin.39
Suggestions and future directions
It is important to acknowledge that these metals imaging
techniques are not without limitations. In general, the spatial
resolution and sensitivity are negatively correlated. A smaller
spot or beam size yields a reduced signal. In addition, none of
the methods presented has a high throughput capability; all
require a relatively long measuring time range. Care should be
taken that metals of interest should be not washed out during
the sample preparation. Formalin-fixed and paraffin-
embedded tissue should be de-paraffinized prior to LA-ICP-
MS, because paraffin can contaminate the ion source of the
mass spectrometer. However, this preparation can be used
directly for SXRF. In some studies, the lower concentrations
of some metals such as Fe were measured using formalin-fixed
and paraffin-embedded tissue.39 This could have been due to
leaching of the metals from the tissues into the formalin
solution or following paraffin embedding. However, this
effect should have been consistent in all tissues studied,
because they are all fixed in formalin and further processed
using a standardized protocol.39 Frozen processed samples are
acceptable for all three metallomics techniques mentioned in
this article, and this method theoretically protects the native
state of the tissue in vivo (particularly with respect to the
preservation of diffusible ions). However, such samples are
more difficult to prepare and transport. Moreover, SIMS,
SXRF and LA-ICP-MS cannot analyze live cells up to
now. As a complementary approach, membrane-diffusible
fluorescent probes can overcome this limitation to examine
the subcellular availability of transition metal cations, such as
Zn40 or Cu.41 However, little is known about whether such
probes can attach covalently to important functional groups,
thereby introducing unnatural charges into cells. And the
metal specificity/selectivity of fluorescence probe toward one
particular metal is not that of element based mass
spectrometry. Therefore, it is important to carefully consider
the pros and cons of each method during experimental design.
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Nevertheless, recent publications demonstrate that the
sensitivity, spatial resolution, specificity, and quantification
of bioimagining of metals are suitable for biomedical research.
However, most of these publications focus on the physiopatho-
logical mechanisms of neurological diseases. Relatively few
studies have been performed using other disease models such
as cardiovascular disease. As a useful attempt, we recently
applied LA-ICP-MS technique to determine and quantify the
metal distribution in mouse heart.42 In the future, it will be
important to apply these powerful techniques to further investi-
gate the metal distribution in various human diseases.
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